TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro

Antivir Ther. 2005;10(8):967-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Retroviral Agents / pharmacology*
  • CCR5 Receptor Antagonists*
  • Cells, Cultured
  • Drug Synergism
  • HIV-1 / drug effects*
  • Imidazoles / pharmacology*
  • Sulfoxides

Substances

  • Anti-Retroviral Agents
  • CCR5 Receptor Antagonists
  • Imidazoles
  • Sulfoxides
  • cenicriviroc